US Nutrition Startup Berry Street Merges With India’s Healthify Amid Rising GLP-1 Demand
United States nutrition startup Berry Street has announced a merger with Indian digital health firm Healthify to tap into the growing global adoption of GLP-1 weight-loss medications. The combined entity will leverage both clinical networks and artificial intelligence coaching to address expanding demand for metabolic healthcare.
What Happened
Berry Street announced on Monday that it has completed a merger with Healthify, a startup backed by Khosla Ventures. The companies chose not to disclose the financial terms of the transaction. Under the leadership agreement, Berry Street founder Noah Kotlove and Healthify founder Tushar Vashisht will lead the newly formed organisation together as co-CEOs.
Geographically, the merged enterprise will tailor its branding by region: it will function under the Berry Street name inside the United States, while retaining the Healthify brand across India and other international markets.
Key Highlights
- Leadership Structure: Noah Kotlove and Tushar Vashisht will act as co-CEOs of the combined business.
- Regional Branding: The company will operate as Berry Street in the US market and as Healthify in India and other geographies.
- Market Outlook: A JP Morgan report published this year projects that more than 30 million people in the United States will use GLP-1 drugs by 2030.
- Healthify Scale: Healthify has raised over $150 million in total funding according to Crunchbase, expanded into the US last year, introduced GLP-1 programs in India, and reports serving more than 45 million users through AI and human coaching.
- Berry Street Infrastructure: Berry Street maintains a network of over 2,000 clinics, offers insurance-covered GLP-1 support, and previously secured $50 million in funding from investors including Northzone, Sofina, and FJ Labs.
Why This Matters
The merger is positioned directly around the escalating popularity of GLP-1 treatments for weight management. According to research published this year by JP Morgan, over 30 million individuals in the US are projected to be on GLP-1 medications by the end of the decade.
By joining forces, the two businesses combine distinct operational assets. Healthify brings an established mobile platform delivering AI-powered and human coaching, while Berry Street contributes an established clinical footprint across the US that includes clinic networks and insurance coverage integration.
Commenting on the tie-up, Healthify CEO Tushar Vashisht stated that the partnership provides the clinical backbone and insurance coverage infrastructure required to expand their AI-driven nutritional coaching in the US market. Vinod Khosla, founder of Khosla Ventures, highlighted that pairing artificial intelligence with a clinical network creates an integrated platform for metabolic care and dietary guidance.
What to Watch Next
Moving forward, the integrated entity will maintain dual operations, running services under the Berry Street banner in the US and under Healthify in India and other regional territories, as both platforms coordinate their clinical infrastructure and nutrition coaching tools.
Frequently Asked Questions
What are the financial terms of the Berry Street and Healthify merger?
The financial details of the transaction have not been disclosed by either company.
Who will lead the merged company?
Berry Street founder Noah Kotlove and Healthify founder Tushar Vashisht will serve as co-CEOs of the merged business.
How will the platforms operate in different regions?
The company will maintain the Berry Street brand for its operations in the United States, while continuing under the Healthify name in India and other markets.
Source: TechCrunch